Peter Diamandis Singularity University Global Summit 2018

Why the Future Is Arriving Faster Than You Think

Why the Future Is Arriving Faster Than You Think

People have no idea how fast the world is changing. So said Peter Diamandis to the audience at Singularity University’s Global Summit, taking place this week in San Francisco. Diamandis believes the convergence of multiple technologies is transforming business models, and they’re never going back. For starters, the way businesses are born (in someone’s garage, at a college dorm, on a computer or smartphone screen) and come to thrive (through digitization that leads to exponential growth), in the 21st century is radically different than the way they used to do so 100 or even 50 years ago. But business models may be the least of it. Diamandis said, “Every single walk of life is going to change. Not in 20–30 years, but this decade.” He described the forces he believes are accelerating this rate of change.

Moore’s Law

Gordon Moore famously predicted, in 1965, that computer chips would double in processing power while halving in cost every 18–24 months thereafter. Moore’s Law turned out to be uncannily accurate, and as a result we’ve seen a massive increase in computing power at ever-decreasing costs. Diamandis asked the audience to consider what kind of computing device they could buy with $1,000 10 years ago as opposed to now—and to imagine how that difference will translate 10 years down the road, too. Besides making computers more widely available to the average person, the speed/cost curve is pushing multiple related technologies forward more quickly. “As computational power gets faster,” Diamandis said, “so do networks and sensors, synthetic biology, robotics, 3D printing—and the convergence of these is what’s transforming business models.” Speed begets speed, at least when it comes to tech.

Time Abundance

Think about how you spend your time on a day-to-day basis. For a good chunk of it is, you’re likely  looking at a screen, be it a computer, phone, television, or other device. Another chunk is spent enjoying the company of friends or loved ones, another eating, and so on. These are all pretty standard activities. But what most of us don’t consider is how dramatically the way humans spend our waking hours has changed over the centuries. “We used to have to forage for firewood, water, and food,” Diamandis said. “Tech begins to liberate us. It gives us a vacation from survival.” Stopping into your local grocery to grab ingredients for dinner takes so much less time than hunting or harvesting it. Buying ready-made food that’s already been heated or refrigerated for you takes even less time.
Peter Diamandis Singularity University Global Summit 2018
Peter Diamandis at Singularity University’s Global Summit in San Francisco
What we’re doing with all the extra time technology has given us is—you guessed it—inventing more technology. “The amount of time we have to innovate is massively increasing,” Diamandis said. Granted, we don’t always choose to use our extra time wisely—but Diamandis’ optimistic take is that the more time tech frees up for us, the better tech we’ll in turn be able to build.

Capital Abundance

A lot of extra time may not get you too far (innovation-wise, at least) if you don’t have any money. But the amount of money available to entrepreneurs has skyrocketed, largely thanks to the way that money is raised and the diversity of sources it comes from. According to Diamandis, there’s more capital available now than there has been at any other time in human history. Crowdfunding has made it possible for someone in a remote part of the world to reach out to people in cities or other countries and get money to start a business. 2017 saw new records in venture investing in the US, Asia, and Europe. Initial coin offerings (ICOs) raise huge amounts of money in remarkably short amounts of time. State-owned sovereign wealth funds as well as privately-held funds (most notably Softbank CEO Masayoshi Son’s $100 billion all-tech Vision Fund) are investing globally, often with a heavy focus on technology. “The velocity of capital that’s flowing is unprecedented,” Diamandis said. “We’re seeing massive investments like never before, not keeping technology at the norm, but actually accelerating it.”

Demonetization

Thanks to digitization and automation, the cost of everything from computing to storage to launching a startup is massively demonetizing. The cost of sequencing a human genome is a perfect (and still shocking) example—sequencing the first human genome cost an estimated total of $2.7 billion; now a startup is aiming to do it for $100. Diamandis himself started a space tourism company called BlastOff! in 1999. “Our cost for getting this company started—for servers, bandwidth, software, everything—was about five million dollars,” he said. Now the cost of starting a business in the US is estimated at $2,000 to $5,000. Cheap credit means more people are willing to take the financial risk of starting a business, and the tools needed to make those businesses successful cost less, too. Phone calls between different countries used to cost dollars per minute—now there are multiple ways to make those calls for free. Connectivity is faster and cheaper than it’s ever been. Businesses can advertise for free or cheap on social media and other online platforms. “Your dollar now goes ten times or a hundred times farther,” Diamandis said.

Communications Abundance

About half the world is currently connected to the internet. But what about the other half? According to Diamandis, 4.2 billion new minds will be coming online in the next 7 years, and they’re going to accelerate the future. “It’s no longer just Silicon Valley,” he said. “It’s the world. What are these people going to invent, create, and discover?” Google, OneWeb, and SpaceX are all working to blanket the earth in high-speed internet, be it via balloons in the stratosphere or satellite constellations in space. China plans to deploy 5G by 2020, and some US telecom companies are starting deployment this year. Besides making your phone 100 times faster, 5G will enable functions like remote precision medicine, interconnected networks of driverless vehicles, virtual and augmented reality, and the sensors and actuators that make up the Internet of Things. “The point is this,” Diamandis said. “In 2017 we had half the world connected—3.8 billion people. By 2022–2025, we’re going to see 8 billion people connected, and at a gigabit connection speed, with access to the world’s information.”

Increased Genius

In the past—and in many parts of the world, the present—people with great ideas who lived in small, remote villages often succumbed to their ingenuity being lost. “You could be the smartest person in the village, but you were stuck there,” Diamandis said. With no connectivity and no way to share knowledge with the larger world, there wasn’t another option. Increasingly as more of the world gets connected, people have the ability to make their ideas known everywhere on the planet. And it’s not just people being connected, he added—their brains may soon be connected too. Companies like Kernel, Neuralink, OpenWater, and BrainGate—among others—are all working on brain-computer communications technology. Diamandis believes this tech will yield (and preserve) a million-fold more intelligence. “Human intelligence is going to be the dominant driver in competitiveness in the century ahead,” he said.

Increased Longevity

It’s generally accepted in the US and elsewhere that once you reach an age somewhere between 60–70, it’s time to hang up your boots, sit back, and relax—for the rest of your life. But, Diamandis argued, “I know a lot of 65- to 70-year-olds who are at the top of their game, and the last thing they want to do is retire. This is when they have the most contacts, the most knowledge, the most wisdom.” Diamandis thinks we’ll soon make 100 the new 60, and longevity is at the center of many companies’ radars, with life-extending tech in the works. Senolytic medicine is working to increase lifespan by selectively killing off aging cells. 3D printing is making slow but steady progress towards being able to print functioning human organs. CRISPR is being used to try to engineer away genetic diseases.

What Is Longevity Escape Velocity?

Longevity escape velocity is defined as the point at which, for every year you’re alive, you can extend your life by more than one year. “We’ll reach that 12 years from now,” Diamandis said. Whether or not the theoretical outcome—living forever—is actually desirable is another story.

What It All Means? Speed.

To sum it all up, what we’ve got is more people sharing more knowledge, at faster speeds and lower costs, than ever before. If speed has already begotten speed, then, it seems the most likely scenario is this phenomenon experiencing even more growth and acceleration going forward. So how do we all take part in it? What if things change too fast for us to keep up? Diamandis is an eternal optimist, and he believes these quicker speeds of change are bringing us an increase in resources to make that change positive. As he put it, “The world is getting faster, and the power you have to change the world is getting greater.” Image Credit: Sorakrai Tangnoi / Shutterstock.com

New CRISPR Method Takes on Duchenne Muscular Dystrophy

New CRISPR Method Takes on Duchenne Muscular Dystrophy

The advance of CRISPR gene editing technology, which uses an RNA strand to guide an enzyme called Cas9 to cut a specific portion of DNA, has raised concerns and sparked debate as people envision a not-so-distant future populated by bioengineered super-crops, genetically flawless pets, and customized babies. While the method could be used for these purposes, it’s also showing potential as a valuable medical tool, with a seemingly new condition added each week to the list of what CRISPR may one day cure. One recent addition to that list is Duchenne muscular dystrophy (DMD). In a study from University of Texas Southwestern Medical Center, researchers used CRISPR to make a single cut at a few strategic points along DNA in cells derived from DMD patients, with the result of potentially correcting most of the 3,000 gene mutations that cause DMD. DMD is a genetic disorder characterized by progressive muscle degeneration and weakness. It mostly affects boys and is caused by defects in the gene that makes dystrophin, a protein that helps strengthen muscle fibers in skeletal and cardiac muscles. Many patients end up in wheelchairs, on respirators, or both, and while advances in cardiac and respiratory care have increased life expectancy into the early 30s, there’s still no cure for the condition. The study on CRISPR for DMD was the cover story of this month’s Science Advances, and it builds on previous studies led by Dr. Eric Olson, director of UT Southwestern’s Hamon Center for Regenerative Science and Medicine, in which CRISPR was used to correct a single gene mutation that caused DMD in mice. The new study showed that various DMD-related mutations can be corrected in human cells by eliminating flawed splice sites in genomic DNA. These splice sites instruct genes to build abnormal dystrophin molecules. The protein then doesn’t function as it should to keep muscle cells intact, and muscles start to break down. Researchers developed 12 guide RNAs to find mutation sites along the dystrophin gene. They cut the DNA at these locations and, in doing so, directed the cellular machinery to skip over the faulty protein sequences. Once the gene was successfully edited, it started building functional dystrophin protein, enhancing the function of muscle tissue. “We found that correcting less than half of the cardiomyocytes (heart muscle cells) was enough to rescue cardiac function to near-normal levels in human-engineered heart tissue,” said Dr. Chengzu Long, lead author of the study and assistant professor of medicine at New York University Langone Health. This single-cut method is an efficient alternative to developing a separate molecular treatment for each one of the gene mutations that cause DMD, and could potentially be used to correct other single-gene mutations like cystic fibrosis or sickle cell anemia. “Not only did we find a practical way of treating many mutations, we have developed a less disruptive method that skips over defective DNA instead of removing it,” said Dr. Rhonda Bassel-Duby, co-author of the study and professor of molecular biology at UT Southwestern. “The genome is highly structured and you don’t want to remove DNA that could potentially be important.” She added that while single-cut editing may be useful for treating other single-gene diseases, the genes involved must still be able to function after certain DNA or RNA sequences are removed. Before we sing CRISPR’s praises too loudly or start banking on it curing all our ailments, though, we must keep in mind that the tool is still very new, and we don’t really know what long-term results or late-onset side effects its use could engender. In fact, we’re not even sure it’ll always work in its current form on humans; one recent study found that some people may be “immune” to CRISPR, as an adaptive immune response can be triggered in people who have been exposed to the bacteria that’s used to engineer CRISPR proteins. Clinical trials using CRISPR to cure blood disorders and sickle-cell disease in humans are slated to start this year in the US. Human trials have already begun in China, where CRISPR is being used to treat cancer and HIV. No peer-reviewed studies from these trials have been published yet, but doctors claim the tool has succeeded in improving some patients’ conditions. Dr. Olson’s lab will continue testing its DMD method for side effects and will also look for ways to improve the precision of the guide RNAs. The team’s work led to the creation of biotech company Exonics Therapeutics, which has licensed the technology from UT Southwestern and is working to optimize the approach and extend it to other neuromuscular diseases. “This is a major advance,” Dr. Bassel-Duby said. “Many different therapies have been put forward, but this one provides real hope to extend and improve the quality of patients’ lives.” Image Credit: nobeastsofierce / Shutterstock.com